![]() |
|
|
Vol. 27, Issue 6, 645-650, June 1999
Clinical Pharmacology Laboratory, Departments of Pharmacology and
Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh,
Pennsylvania
A comparative study of the plasma pharmacokinetics and tissue
distribution of the d-threo enantiomers
of methylphenidate (MPH), para-bromomethylphenidate
(p-Br MPH), and
para-methoxymethylphenidate (p-OCH3 MPH) was conducted in rats
after i.p. administration of a 37 µmol/kg dose. The plasma kinetic
data was fit to a two-compartment model with absorption and lag time as
well as evaluated by noncompartmental methods. All three compounds
attained maximal concentration within 10 min of injection. Calculated
mean residence time and elimination half-life values for
d-p-Br MPH were significantly longer than those for d-MPH and
d-p-OCH3 MPH, and clearance
of the bromo derivative was substantially lower than the latter two
compounds. Tissue distribution studies of the three
d-threo enantiomers revealed that
para-substitution of d-MPH had a profound
effect on the distribution pattern of these drugs. The highest
concentration of drug was found in the kidney and lung for
d-MPH, lung and liver for
d-p-Br MPH, and lung and brain for
d-p-OCH3 MPH. The bromo
derivative was found in the highest concentration in the central
nervous system at 30, 120, and 180 min whereas levels of
d-MPH were twice as high as
d-p-OCH3 MPH at 30 min but
slightly lower than the latter at 120 min. Related studies on the
lipophilicity, plasma protein binding, and resistance to plasma
degradation of these compounds were also conducted. The combined data
from these experiments along with the pharmacokinetics and central
nervous system distribution of these drugs provide explanations for
discrepancies between the in vivo and in vitro activity of these
compounds described in previous work.
This article has been cited by other articles:
![]() |
R. Kuczenski and D. S. Segal Exposure of Adolescent Rats to Oral Methylphenidate: Preferential Effects on Extracellular Norepinephrine and Absence of Sensitization and Cross-Sensitization to Methamphetamine J. Neurosci., August 15, 2002; 22(16): 7264 - 7271. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kuczenski and D. S. Segal Locomotor Effects of Acute and Repeated Threshold Doses of Amphetamine and Methylphenidate: Relative Roles of Dopamine and Norepinephrine J. Pharmacol. Exp. Ther., March 1, 2001; 296(3): 876 - 883. [Abstract] [Full Text] |
||||